http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2647437-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ef12cc988619c686fa362651f901dbb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate | 2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c138fa0e24536733d7a53a0c5d030f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7e4a9a612111c976f0dc384b31396f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c95667dea5bbdb2d5b97637c5a8bf5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a11d1d0d223617e3487a140f5be48b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34a190a97302177786eb03c620bd0096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff4d30d9dbcfa0b358d991b3ed86903 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47508cf5407adc0c746674ae74374149 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_968054654ceac1242f77dd433f948cc1 |
| publicationDate | 2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2647437-T3 |
| titleOfInvention | Compounds and procedures for treating HIV |
| abstract | A compound that is: 2- (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl) -1,6-dimethyl acid -2- {2- [3- (morpholin-4-yl) azetidin-1-yl] pyridin-4-yl} -1 H -pyrrolo [2,3-b] pyridin-5-yl] acetic acid, 2- acid (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl) -1,6-dimethyl-2- [2- (1-methyl-1H-indazol-5-yl) pyridin-4-yl] -1 H -pyrrolo [2,3-b] pyridin-5-yl] acetic acid, 2- (tert-butoxy) -2- ( 2- {2- [2- (dimethylamino) pyrimidin-5-yl] pyridin-4-yl} -4- (8-fluoro-5-methyl-3,4-dihydro-2H-1- benzopyran-6-yl ) -1,6-dimethyl-1H-pyrrolo [2,3-b] pyridin-5-yl) acetic acid, 2- (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3 , 4-dihydro-2H-1-benzopyran-6-yl) -1,6-dimethyl-2- [2- (pyridin-3-yl) pyridin-4-yl] -1H-pyrrolo [2,3-b ] pyridin-5-yl] acetic acid, 2- (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl) -1 , 6-dimethyl-2- [2- (1-methyl-2,3-dihydro-1 H -indol-5-yl) pyridin-4-yl] -1 H -pyrrolo [2,3-b] pyridin-5- il] acetic acid, 2- (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl) -1,6-dimethyl-2- {2- [1- (oxan-4-yl) -1Hpirazol-4-yl] pyridin-yl} -1H-pyrrolo [2,3-b] pyridin-5-yl] acetic acid 2- (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl) -1,6-dimethyl-2- [2- (4-methylpiperazin-1- yl) pyridin-4-yl] -1 H -pyrrolo [2,3-b] pyridin-5-yl] acetic acid, 2- (tert-butoxy) -2- [4 - (8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl) -1,6-dimethyl-2- {2 - [(4-methylpiperazin-1- yl) carbonyl] pyridin-4-yl} -1H-pyrrolo [2,3-b] pyridin-5-yl] acetic acid, 2- (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3, 4-dihydro-2H-1-benzopyran-6-yl) -1,6-dimethyl-2- [6- (1-methyl-1H-indazol-5- yl) pyridin-3-yl] -1H-pyrrolo [ 2,3-b] pyridin-5-yl] acetic acid, 2- (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6 -yl) -1,6-dimethyl-2- {1 - [(pyridin-3-yl) carbonyl] - 1,2,3,6-tetrahydropyridin-4-yl} -1H-pyrrolo [2,3-b ] pyridin-5-yl] acetic acid, 2- (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl) -1 , 6-dimethyl-2- {4 - [(pyridin-3- yl) carbonyl] piperazin-1-yl} -1 H -pyrrolo [2,3-b] pyridin-5-yl ] acetic acid 2- (tert-butoxy) -2- [4- (8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl) -1,6-dimethyl-2 - {2- [4- (oxetan-3- il) piperazin-1-yl] pyridin-4-yl} -1H-pyrrolo [2,3-b] pyridin-5-yl] acetic acid, 2- (tert) -butoxy) -2- (4- (8-fluoro-5-methylchroman-6-yl) -1,6-dimethyl-2- (3- (4- (tetrahydro-2H-pyran-4-yl) piperazin- 1-yl) -1,2,4-thiadiazol-5-yl) -1 H -pyrrolo [2,3-b] pyridin-5-yl) acetic acid, 2- (tert-butoxy) -2- (4- (8-fluoro-5-methylchroman-6-yl) -1,6-dimethyl-2- (3- (4- (tetrahydro-2H-pyran-4-yl) piperazin-1-yl) -1,2, 4-oxadiazol-5-yl) -1H-pyrrolo [2,3-b] pyridin-5-yl) acetic acid, or 2- (tert-butoxy) -2- (4- (8-fluoro-5-methylchroman) -6-yl) -1,6-dimethyl-2- (5- (1-methyl-1H-indazol-5-yl) -1,3,4-oxadiazol-2- yl) -1H-pyrrolo [2, 3-b] pyridin-5-yl) acetic, or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2012-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 552.